Vancouver
Originally published online as doi:10.1189/jlb.0806538 on March 27, 2007

Published online before print March 27, 2007
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
jlb.0806538v1
81/6/1404    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brekke, O.-L.
Right arrow Articles by Mollnes, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brekke, O.-L.
Right arrow Articles by Mollnes, T. E.
(Journal of Leukocyte Biology. 2007;81:1404-1413.)
© 2007 by Society for Leukocyte Biology

The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood

Ole-Lars Brekke*,{dagger},1, Dorte Christiansen*, Hilde Fure*, Michael Fung{ddagger} and Tom E. Mollnes*,§

* Department of Laboratory Medicine, Nordland Hospital, Bodø, Norway;
{dagger} Institute of Medical Biology, University of Tromsø, Tromsø, Norway;
{ddagger} Tanox Inc., Houston, Texas, USA; and
§ Institute of Immunology, Rikshospitalet University Hospital and University of Oslo, Oslo, Norway

1 Correspondence: Department of Laboratory Medicine, Nordland Hospital, N-8092 Bodø, Norway. E-mail: ole.lars.brekke{at}nlsh.no

The relative role of complement and CD14 in Escherichia coli-induced leukocyte CD11b up-regulation, phagocytosis, and oxidative burst in human whole blood was examined. The highly specific thrombin inhibitor lepirudin was used as anticoagulant, as it does not affect complement activation. Complement inhibition at the level of C3 (anti-C2 and anti-factor D) and C5 (C5a receptor antagonist and anti-C5/C5a) efficiently inhibited CD11b up-regulation, phagocytosis, and oxidative burst in granulocytes. Monocyte activation was generally less complement-dependent, but when C3 activation was blocked, a pronounced inhibition of phagocytosis and oxidative burst was obtained. Only the combination of anti-C2 and antifactor D blocked E. coli C3 opsonization completely. Whole E. coli, disrupted E. coli, and the C3-convertase activator cobra venom factor up-regulated CD11b rapidly on both cell types, proportional to their complement activation potential in the fluid phase. In comparison, purified LPS at concentrations comparable with that present in the E. coli preparations did not activate complement. Oxidative burst was induced only by whole bacteria. Finally, the combination of complement inhibition and anti-CD14 completely blocked E. coli-induced granulocyte and monocyte CD11b up-regulation and quantitatively, virtually abolished phagocytosis. The results indicate that complement and CD14, despite differential effects on granulocytes and monocytes, are the two crucial, quantitative factors responsible for E. coli-induced CD11b, phagocytosis, and oxidative burst in both cell types.

Key Words: sepsis • endotoxin • complement receptor 3




This article has been cited by other articles:


Home page
FASEB J.Home page
E. B. Thorgersen, B. C. Hellerud, E. W. Nielsen, A. Barratt-Due, H. Fure, J. K. Lindstad, A. Pharo, E. Fosse, T. I. Tonnessen, H. T. Johansen, et al.
CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs
FASEB J, March 1, 2010; 24(3): 712 - 722.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. B. Thorgersen, A. Pharo, K. Haverson, A. K. Axelsen, P. Gaustad, G. J. Kotwal, G. Sfyroera, and T. E. Mollnes
Inhibition of Complement and CD14 Attenuates the Escherichia coli-Induced Inflammatory Response in Porcine Whole Blood
Infect. Immun., February 1, 2009; 77(2): 725 - 732.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. A. Flierl, D. Rittirsch, B. A. Nadeau, D. E. Day, F. S. Zetoune, J. V. Sarma, M. S. Huber-Lang, and P. A. Ward
Functions of the complement components C3 and C5 during sepsis
FASEB J, October 1, 2008; 22(10): 3483 - 3490.
[Abstract] [Full Text] [PDF]